Items where authors include "Chandra, A."

Article

Maccari, M.E. orcid.org/0000-0001-6488-7622, Wolkewitz, M., Schwab, C. et al. (125 more authors) (2023) Activated Phosphoinositide 3-Kinase δ Syndrome: Update from the ESID Registry and comparison with other autoimmune-lymphoproliferative inborn errors of immunity. Journal of Allergy and Clinical Immunology, 152 (4). 984-996.E10. ISSN 0091-6749

Kemp, S.A., Collier, D.A., Datir, R.P. et al. (34 more authors) (2021) SARS-CoV-2 evolution during treatment of chronic infection. Nature, 592 (7853). pp. 277-282. ISSN 0028-0836

Shariatzadeh, M., Chandra, A., Wilson, S.L. et al. (14 more authors) (2020) Distributed automated manufacturing of pluripotent stem cell products. International Journal of Advanced Manufacturing Technology, 106 (3-4). pp. 1085-1103. ISSN 0268-3768

Stacey, G.N., Andrews, P. orcid.org/0000-0001-7215-4410, Barbaric, I. et al. (17 more authors) (2019) Stem cell culture conditions and stability: a joint workshop of the PluriMes Consortium and Pluripotent Stem Cell Platform. Regenerative Medicine, 14 (3). pp. 243-255. ISSN 1746-0751

Stacey, G., Andrews, P.W. orcid.org/0000-0001-7215-4410, Asante, C. et al. (41 more authors) (2018) Science-based assessment of source materials for cell-based medicines: report of a stakeholders workshop. Regenerative Medicine, 13 (8). pp. 935-944. ISSN 1746-0751

Tuijnenburg, P., Lango Allen, H., Burns, S.O. et al. (85 more authors) (2018) Loss-of-function nuclear factor κB subunit 1 (NFKB1) variants are the most common monogenic cause of common variable immunodeficiency in Europeans. Journal of Allergy and Clinical Immunology, 142 (4). pp. 1285-1296. ISSN 0091-6749

Stark, A.-K., Chandra, A., Chakraborty, K. et al. (13 more authors) (2018) PI3Kδ hyper‐activation promotes development of B cells that exacerbate Streptococcus pneumoniae infection in an antibody‐independent manner. Nature Communications, 9. ISSN 2041-1723

Arce Vargas, F., Furness, A.J.S., Litchfield, K. et al. (249 more authors) (2018) Fc effector function contributes to the activity of human anti-CTLA-4 antibodies. Cancer Cell, 33 (4). 649-663.e4. ISSN 1535-6108

Maccari, M.E., Abolhassani, H., Aghamohammadi, A. et al. (64 more authors) (2018) Disease evolution and response to rapamycin in Activated Phosphoinositide 3-Kinase delta syndrome: the european society for immunodeficiencies-Activated Phosphoinositide 3-Kinase d syndrome registry. Frontiers in Immunology, 9. 543. ISSN 1664-3224

Condliffe, A.M. and Chandra, A. (2018) Respiratory manifestations of the activated phosphoinositide 3-kinase delta syndrome. Frontiers in Immunology, 9. 338. ISSN 1664-3224

Coulter, T.I., Chandra, A., Bacon, C.M. et al. (55 more authors) (2017) Clinical spectrum and features of activated phosphoinositide 3-kinase δ syndrome: A large patient cohort study. Journal of Allergy and Clinical Immunology, 139 (2). 597-606.e4. ISSN 0091-6749

Lucas, C.L., Chandra, A., Nejentsev, S. et al. (2 more authors) (2016) PI3Kδ and primary immunodeficiencies. Nature Reviews Immunology, 16 (11). pp. 702-714. ISSN 1474-1733

Lucas, C.L., Chandra, A., Nejentsev, S. et al. (2 more authors) (2016) PI3Kδ and primary immunodeficiencies. Nature Reviews Immunology, 16 (11). pp. 702-714. ISSN 1474-1733

Williams, D.J., Archer, R., Archibald, P. et al. (46 more authors) (2016) Comparability: manufacturing, characterization and controls, report of a UK Regenerative Medicine Platform Pluripotent Stem Cell Platform Workshop, Trinity Hall, Cambridge, 14-15 September 2015. Regenerative Medicine, 11 (5). pp. 483-492. ISSN 1746-0751